[1]
A. Mousa, M. Petrovic, and N. E. Fleshner, “Prevalence and predictors of cannabis use among men receiving androgen-deprivation therapy for advanced prostate cancer”, CUAJ, vol. 14, no. 1, pp. E20–6, Jun. 2019.